Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
AKTIENPREIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionNorges Bank
Latest Disclosed Ownership1,146,896 shares
Latest Disclosed Value $ 162,664,260
Norges Bank ownership in NB3 / Neurocrine Biosciences, Inc.

On February 10, 2026 - Norges Bank filed a 13F-HR form disclosing ownership of 1,146,896 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $138,487,692 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Neurocrine Biosciences, Inc.. The current value of the position is $154,429,546 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-10 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,146,896 1,146,896 162,664 0.0174
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -972,856 -100.00 0 -100.00
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 972,856 -26,965 -2.70 122,278 10.58 0.0153
2026-05-11 2025-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 999,821 674,526 207.36 110,580 149.04 0.0155
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 325,295 -25,769 -7.34 44,403 9.77 0.0058
2025-11-12 2024-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 351,064 -98,501 -21.91 40,450 -34.64 0.0057
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 449,565 24,349 5.73 61,892 5.53 0.0092
2025-05-14 2024-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 425,216 154,034 56.80 58,646 64.13 0.0093
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 271,182 191,277 239.38 35,731 297.49 0.0062
2024-11-13 2023-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 79,905 25,578 47.08 8,989 75.46 0.0018
2024-08-14 2023-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 54,327 -741,083 -93.17 5,123 -93.64 0.0010
2024-05-15 2023-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 795,410 -140,505 -15.01 80,511 -27.98 0.0176
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 935,915 62,242 7.12 111,786 20.47 0.0269
2023-11-13 2022-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 873,673 18,731 2.19 92,793 11.34 0.0247
2023-08-14 2022-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 854,942 23,883 2.87 83,340 6.97 0.0215
2023-05-12 2022-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 831,059 62,643 8.15 77,912 19.05 0.0170
2022-03-09 2021-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 768,416 3,997 0.52 65,446 -10.73 0.0135
2022-11-14 2021-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 764,419 31,217 4.26 73,315 2.75 0.0162
2022-08-15 2021-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 733,202 47,600 6.94 71,355 7.02 0.0155
2022-05-09 2021-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 685,602 -21,800 -3.08 66,675 -1.67 0.0153
2021-03-02 2020-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 707,402 -31,949 -4.32 67,804 -4.63 0.0158
2021-11-12 2020-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 739,351 -13,200 -1.75 71,096 -22.56 0.0189
2021-08-13 2020-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 752,551 -38,284 -4.84 91,811 34.13 0.0264
2021-05-07 2020-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 790,835 4,921 0.63 68,447 -18.98 0.0244
2020-03-03 2019-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 785,914 -70,697 -8.25 84,478 9.44 0.0236
2020-11-13 2019-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 0.00 77,190 6.73 0.0236
2020-08-13 2019-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 0.00 72,323 -4.17 0.0223
2020-05-11 2019-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 0.00 75,467 23.37 0.0244
2019-03-04 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 0.00 61,171 -41.92 0.0228
2019-12-02 2018-09-30 13F/A-3 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 0.00 105,320 25.15 0.0342
2019-12-02 2018-09-30 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 105,320 0.0342
2019-11-12 2018-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 0 105,320 0.0342
2019-08-12 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 856,611 -19,657 -2.24 84,154 15.80 0.0289
2019-05-15 2018-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 876,268 0 0.00 72,669 6.88 0.0263
2018-03-05 2017-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 876,268 0 0.00 67,990 26.62 0.0244
2018-11-13 2017-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 876,268 0 0.00 53,698 33.22 0.0204
2018-07-24 2017-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 876,268 80,974 10.18 40,308 17.05 0.0160
2018-05-11 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 795,294 -103,360 -11.50 34,436 -0.98 0.0141
2017-03-02 2016-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 898,654 0 0.00 34,777 -19.99 0.0152
2017-11-13 2016-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 898,654 0 0.00 43,465 6.42 0.0205
2017-08-09 2016-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 898,654 181,241 25.26 40,844 43.95 0.0194
2017-05-10 2016-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 717,413 -31,894 -4.26 28,374 -33.06 0.0140
2016-04-18 2015-12-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 749,307 33,919 4.74 42,389 48.91 0.0211
2016-03-16 2015-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 749,307 0 42,389 0.0213
2016-11-14 2015-09-30 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 715,388 247,402 52.87 28,466 27.36 0.0149
2016-08-12 2015-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 467,986 296,151 172.35 22,351 227.54 0.0112
2016-05-13 2015-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 171,835 171,835 0.00 6,824 0.0033
2016-04-18 2014-12-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.